Aspergilloma

Aspergilloma and chronic cavitary pulmonary aspergillosis (CCPA) refer to the inert saprophytic colonization of preexisting cavitary spaces in the pulmonary parenchyma, along with their presentation and complications. These conditions fall under the broader category of chronic pulmonary aspergillosis (CPA), which includes several distinct clinical entities, such as aspergilloma, CCPA, chronic fibrosing pulmonary aspergillosis (CFPA), Aspergillus nodules, and subacute invasive aspergillosis. Importantly, the overlap in clinical and radiographic features among CPA entities has led to confusion in interpreting the literature on their natural history and management. This confusion is further attributed to the differences in cumulative clinician experience in managing these conditions. Published case series from regions with high tuberculosis (TB) prevalence may present different diagnostic and management approaches compared to areas with lower prevalence, where aspergilloma is less common. Management approaches remain controversial due to the existence of small case series in the literature, with a lack of extensive, prospective, randomized studies. Diagnosing and managing these chronic fungal infections is complex and challenging, as radiographic features often overlap with those of other lung diseases. Moreover, as CPA usually develops most often in diseased lungs, it is difficult to determine the extent of radiological distortion caused by the fungus versus the underlying lung disease. Consensus Definitions of Chronic Pulmonary Aspergillosis The European Society for Clinical Microbiology and Infectious Diseases, the European Respiratory Society, and the Infectious Diseases Society of America have established consensus definitions for CPA, and their diagnostic criteria are mentioned below. Simple Aspergilloma A single pulmonary cavity containing a fungal ball, with serological or microbiological evidence of Aspergillus spp. in a non-immunocompromised patient. The patient experiences minor or no symptoms, and there is no radiological progression over at least 3 months of observation. Chronic Cavitary Pulmonary Aspergillosis One or more pulmonary cavities (with either thin or thick walls), possibly containing one or more aspergillomas or irregular intraluminal material, along with serological or microbiological evidence of Aspergillus spp. This condition is associated with significant pulmonary and/or systemic symptoms and overt radiological progression, such as new cavities, increasing pericavitary infiltrates, or increasing fibrosis, over at least 3 months of observation. Chronic Fibrosing Pulmonary Aspergillosis Severe fibrotic destruction of at least 2 lobes of the lung complicates CCPA, resulting in significant loss of lung function. When severe fibrotic destruction affects a single lobe with a cavity, it is referred to as CCPA affecting that lobe. The fibrosis typically presents as consolidation, but large cavities surrounded by fibrosis may also be observed. Aspergillus Nodule An unusual form of CPA, Aspergillus nodules may present as one or more nodules that may or may not cavitate. These nodules can mimic conditions such as tuberculoma, lung carcinoma, coccidioidomycosis, and other diagnoses. A definitive diagnosis requires histological examination. While tissue invasion is not typically observed, necrosis is commonly present. Subacute Invasive Aspergillosis Subacute invasive aspergillosis typically occurs in mildly immunocompromised patients over a period of 1 to 3 months. This infection presents with variable radiological features, including cavitation, nodules, and progressive consolidation with abscess formation. Biopsy reveals hyphae invading lung tissue, and microbiological investigations, including positive Aspergillus galactomannan antigens in blood or respiratory fluids, are consistent with invasive aspergillosis. The above definitions are not mutually exclusive, and progression between disease categories may occur. While not fully understood, the factors contributing to disease progression likely include a combination of immune function, treatment response, and preexisting lung pathology. This activity focuses on pulmonary aspergilloma and CCPA, with the terms aspergilloma, pulmonary mycetoma, and fungus ball used to describe the chronic colonization of Aspergillus species within preexisting lung cavities or bronchiectatic parenchyma.